Trial Profile
A prospective study evaluating dendritic cells functions in correlation with interferon and ribavirin therapy in chronically infected HCV children.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary) ; Ribavirin (Primary) ; Resiquimod
- Indications Hepatitis C
- Focus Therapeutic Use
- 16 Jun 2016 New trial record